Stock price when the opinion was issued
Has been very negative on this name. Thematically they have incurred a ton of debt to develop oil sands and when you are the marginal cost barrel in the oil sands and financing it with debt, it is a risky business and it didn’t work out for them. Have gone through a process of management change, selling assets, etc. Still have a lot of challenges ahead.
For many years they were able to live off the model of their laboratory business and contracts with the governments but Ministries of Health are getting tighter and tighter. Also, had some problems with their US exposure in radiology that didn’t work out. New management. For the time being, they tend to maintain their dividend but they would really like to lever the higher margin lab business.